🔍 Key Findings
- 20.6% of dogs had a preoperative prolongation in PT or aPTT, but only 5.6% had both prolonged.
- Hemangiosarcoma was the only tumor type significantly associated with both PT and aPTT prolongation (37.5% of hemangiosarcoma cases, p < .001).
- Dogs with both PT and aPTT prolongations were 6.5× more likely to have emergency surgery (p < .001) and 2.5× more likely to have hemoabdomen (p = .0022).
- 60% of dogs with both PT and aPTT prolongation required blood transfusion (p < .001).
- Only 1.9% of all dogs had both PT and aPTT prolonged by >25%, suggesting limited clinical utility of routine PT/aPTT testing.
- Platelet count <50,000/μL was rare (1.5%) and not associated with PT/aPTT changes or transfusions.
- Routine PT/aPTT testing offers low diagnostic yield in elective liver lobectomy cases.
- Authors recommend case-by-case PT/aPTT screening, especially when hemangiosarcoma or bleeding tendencies are suspected.